Evidence map›Paper›PMID 42113606›Full record

ArticleBiology of reproduction2026

Generation of human primordial germ cell-like cells from cumulus and blood cell-derived isogenic human induced pluripotent stem cells†.

Silvia Llonch, Laurie Pinel, Tom Mattimoe, Jacqueline Severino, Filippo Zambelli, Anna Mallol, Karen Freire Carvalho, Laura Batlle-Morera, Rita Vassena, Bernhard Payer

Abstract read
In one paragraph

Article in Biology of reproduction, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Silvia LlonchCentre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, Barcelona, Catalonia, Spain.ORCID 0000-0001-6190-0377
Laurie PinelAzrieli Research Centre, CHU Sainte-Justine, Montréal, Québec, Canada.ORCID 0009-0004-7964-2328
Tom MattimoeCentre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, Barcelona, Catalonia, Spain.ORCID 0000-0002-7174-6729
Jacqueline SeverinoCentre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, Barcelona, Catalonia, Spain.ORCID 0000-0001-6959-0342
Filippo ZambelliBasic Research Laboratory-Eugin Group, Barcelona, Catalonia, Spain.ORCID 0000-0001-7275-2947
Anna MallolCentre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, Barcelona, Catalonia, Spain.ORCID 0000-0001-7366-0980
Karen Freire CarvalhoAzrieli Research Centre, CHU Sainte-Justine, Montréal, Québec, Canada.ORCID 0000-0003-3342-2747
Laura Batlle-MoreraCentre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, Barcelona, Catalonia, Spain.ORCID 0000-0002-6924-9002
Rita VassenaBasic Research Laboratory-Eugin Group, Barcelona, Catalonia, Spain.ORCID 0000-0002-0846-0365
Bernhard PayerCentre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, Barcelona, Catalonia, Spain.ORCID 0000-0002-4694-2082

Funding

Agencia de Gestió d'Ajuts Universitaris i de Recerca SGR 01222Agencia de Gestió d'Ajuts Universitaris i de Recerca SGR 346Agencia Estatal de InvestigaciónAXA Research FundCentro de Excelencia Severo Ochoa CEX2020-001049-SCentro de Excelencia Severo Ochoa MCIN/AEI/10.13039/501100011033CIHR 204352Clinica EUGINEpigenetic Effects of Ageing on Human OocytesEuropean Union BFU2017-88407-PEuropean Union's Horizon 2020 research and innovation programme 75442Fondo Europeo de Desarrollo RegionalGeneralitat de Catalunya CERCA ProgrammeISCIII PT2020 Biobancos and Biomodelos call
6 · The paper itself

Abstract

The recent development of in vitro germ cell differentiation from pluripotent stem cells opened the human reproduction field to mechanistic investigations. In combination with induced pluripotent stem cell (hiPSC) reprogramming, in vitro gametogenesis provides an avenue for patient-specific disease modeling approaches. However, further advancements are required, as current protocols are limited to early stages of germ cell development. To get one step closer to this goal, here we aimed to identify optimal conditions for generating high-quality hiPSC lines capable of in vitro germ cell differentiation. We isolated two clinically available somatic cell types, peripheral blood-derived mononuclear cells and cumulus cells from the same female donor, and reprogrammed them into human induced pluripotent stem cells (hiPSCs). We then assessed their differentiation into ectoderm, mesoderm, and endoderm, and evaluated their X-chromosome inactivation status, a critical indicator of stem cell quality. Finally, we compared the capacity of PBMC- and cumulus-derived hiPSCs to differentiate into human primordial germ cell-like cells (hPGCLCs). We found that despite variability between cell lines, hiPSCs from both cell types were capable of generating hPGCLCs and that variations in X-chromosome state did not appear to generally interfere with the process. Our findings provide insight into germ cell differentiation from different clinically available starting materials guiding future patient-specific studies of fertility disorders.

Indexed as

Cumulus CellsGerm CellsInduced Pluripotent Stem CellsLeukocytes, MononuclearCell DifferentiationCells, CulturedCellular ReprogrammingFemaleHumanscumulus cellshiPSC reprogramminghPGCLCsin vitro germ cell differentiationPBMCsX-chromosome inactivation

Identifiers

PMID42113606
PMCPMC13482277

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.